← Back to Search

Vibrotactile Stimulation for Stroke Recovery

Led By Leigh A Mrotek, PhD
Research Sponsored by Marquette University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Stroke survivors who can perform stabilization and grip modulation tasks
Preserved tactile sensation in either the ipsilesional arm and/or thigh
Screening 3 weeks
Treatment Varies
Follow Up across experimental sessions spanning a typical time frame of 4 to 6 weeks
Awards & highlights

Study Summary

This trial will test whether adding vibrotactile stimulation can help improve arm function for people who have lost proprioception after a stroke.

Who is the study for?
This trial is for stroke survivors with mild-to-moderate arm impairment, who can feel touch in the affected arm or thigh and have a minimal ability to extend their wrist. They must be at least 6 months post-stroke from an MCA event, able to consent and follow instructions, and have specific proprioceptive deficits. People with bleeding disorders, muscle diseases like ALS or myasthenia gravis, epilepsy, severe psychiatric conditions, pacemakers or significant heart issues cannot join.Check my eligibility
What is being tested?
The study tests if vibrotactile stimulation—a type of sensory feedback—can help improve arm function after stroke. Thirty participants will try this method while doing tasks like reaching out or simulating drinking from a glass to see if it enhances motor control.See study design
What are the potential side effects?
While not explicitly stated in the provided information, typical side effects of vibrotactile stimulation may include skin irritation where the device is applied and potential discomfort due to vibration.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I had a stroke but can still stabilize and grip objects.
I can feel touch in my arm or thigh on the same side as my lesion.
I can slightly bend my wrist upwards.
I had a stroke in the middle cerebral artery over 6 months ago.
I have mild-to-moderate difficulty moving my arms.
I have trouble sensing joint movement in my elbow on the side of my body opposite to my stronger arm.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~across experimental sessions spanning a typical time frame of 4 to 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and across experimental sessions spanning a typical time frame of 4 to 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Root Mean Square Kinematic Error

Trial Design

2Treatment groups
Experimental Treatment
Group I: Stroke Cohort - Whole Task TrainingExperimental Treatment1 Intervention
Aim2 intervention: Vibrotactile stimulation. Training on only the more complex reaching task using vibrotactile feedback to guide performance
Group II: Stroke Cohort - Progressive TrainingExperimental Treatment1 Intervention
Aim 1 intervention: Vibrotactile stimulation. Progressive training from simple to more complex reaching task using vibrotactile feedback to guide performance
First Studied
Drug Approval Stage
How many patients have taken this drug
Vibrotactile stimulation

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,962 Previous Clinical Trials
2,674,699 Total Patients Enrolled
Marquette UniversityLead Sponsor
62 Previous Clinical Trials
200,293 Total Patients Enrolled
Medical College of WisconsinOTHER
609 Previous Clinical Trials
1,162,571 Total Patients Enrolled

Media Library

Vibrotactile stimulation Clinical Trial Eligibility Overview. Trial Name: NCT03298243 — N/A
Proprioceptive Disorders Research Study Groups: Stroke Cohort - Progressive Training, Stroke Cohort - Whole Task Training
Proprioceptive Disorders Clinical Trial 2023: Vibrotactile stimulation Highlights & Side Effects. Trial Name: NCT03298243 — N/A
Vibrotactile stimulation 2023 Treatment Timeline for Medical Study. Trial Name: NCT03298243 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings for participants in this experiment?

"Affirmative. Per the information hosted on clinicaltrials.gov, this investigation is actively seeking participants and was first posted in October of 2017, with its last edit occuring on May 8th 2023. 58 patients from a single site are needed for the trial to be successful."

Answered by AI

To what extent is this medical trial being utilized by patients?

"Affirmative. The clinical trial is currently recruiting participants, and according to the information hosted on clinicaltrials.gov, this study was first posted on October 30th 2017 and last updated on May 8th 2023. There are 58 patients that need to be recruited from a single medical centre."

Answered by AI
~14 spots leftby Dec 2024